ArticleProceedings of the National Academy of Sciences of the United States of America2025

Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.

Jun Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.